SK Pharmteco

SK Pharmteco is a global leader in contract development and manufacturing services (CDMO), specialising in small molecule APIs, cell and gene therapies, and other advanced pharmaceutical solutions.

A subsidiary of SK Inc., SK Pharmteco operates an extensive network of manufacturing facilities and centres of excellence across the United States, Europe, and South Korea. The company provides a comprehensive suite of services to support pharmaceutical and biotechnology companies from early-stage development through to commercial production. Their expertise lies in process development, regulatory compliance, and scalable manufacturing solutions, enabling clients to bring innovative therapies to market efficiently and safely. Their focus on sustainability and client-centric collaboration has positioned them as a trusted partner in the pharmaceutical industry.

Key Products and Services

• Small Molecule API Manufacturing: Expertise in producing complex APIs for various therapeutic areas.
• Cell and Gene Therapy Solutions: End-to-end support, including CGMP manufacturing, viral vector production, plasmid DNA manufacturing, and autologous/allogeneic cell therapy production.
• Process Development: Scalable, robust processes ensuring seamless tech transfer and compliance from preclinical to commercial stages.
• Analytical Services: Comprehensive testing for safety, potency, stability, and regulatory requirements.
• Regulatory Support: Guidance from clinical trials to regulatory submissions, ensuring global compliance.

SK Pharmteco’s innovative solutions and commitment to excellence have made them a partner of choice for life sciences companies worldwide. By combining cutting-edge technology with flexible, client-focused approaches, they play a pivotal role in advancing global healthcare solutions, delivering therapies that transform patients' lives